Psoriasis could increase the risk of sexual dysfunction, particularly in patients with psychological comorbidity, says a study published in JAMA Dermatology. Here’s what researchers discovered.
Patients receiving ustekinumab or TNFi therapies for psoriasis or psoriatic arthritis experience no substantial difference in risks for atrial fibrillation or major adverse cardiovascular events, a new study showed. Find out more in this article.
This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.
This email was sent by: MultiMedia Healthcare
535 Connecticut Avenue, Suite 300
Norwalk, CT, 06854, USA